Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04830592
Brief Title: A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck (MOAT)

First Submitted : March 31, 2021
First Submitted that Met QC Criteria : March 31, 2021
First Posted : April 5, 2021

Last Update Submitted that Met QC Criteria : April 6, 2021
Last Update Posted : April 9, 2021